文献速递病毒性肝炎

中国乙型肝炎综合干预包投资案例:应用模型辅助国家策略规划

Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究建立中国HBV动态模拟模型,从社会视角评估综合预防与治疗干预包的影响、成本和投资回报。

要点

  • 综合干预包社会投资回报为每投入1美元回报1.57美元。

核心结论

  • 未来数十年HBV相关死亡增加是中国重大公共卫生威胁,需要积极病例发现和获得优化抗病毒治疗来缓解风险。

研究设计与样本

  • 开发中国HBV动态模拟模型,从社会视角评估综合预防和治疗干预包的影响、成本和投资回报。

主要发现

  • 综合干预包社会投资回报为每投入1美元回报1.57美元。

临床怎么用

  • 应用模型支持国家对话和政策规划,推动积极病例发现和优化抗病毒治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2016, the first global viral hepatitis elimination targets were endorsed. An estimated one-third of the world's population of individuals with chronic hepatitis B virus (HBV) infection live in China and liver cancer is the sixth leading cause of mortality, but coverage of first-line antiviral treatment was low. In 2015, China was one of the first countries to initiate a consultative process for a renewed approach to viral hepatitis. We present the investment case for the scale-up of a comprehensive package of HBV interventions. METHODS: A dynamic simulation model of HBV was developed and used to simulate the Chinese HBV epidemic. We evaluated the impact, costs, and return on investment of a comprehensive package of prevention and treatment interventions from a societal perspective, incorporating costs of management of end-stage liver disease and lost productivity costs. RESULTS: Despite the successes of historical vaccination scale-up since 1992, there will be a projected 60 million people still living with HBV in 2030 and 10 million HBV-related deaths, including 5.7 million HBV-related cancer deaths between 2015 and 2030. This could be reduced by 2.1 million by highly active case-finding and optimal antiviral treatment regimens. The package of interventions is likely to have a positive return on investment to society of US$1.57 per US dollar invested. CONCLUSIONS: Increases in HBV-related deaths for the next few decades pose a major public health threat in China. Active case-finding and access to optimal antiviral treatment are required to mitigate this risk. This investment case approach provides a real-world example of how applied modeling can support national dialog and inform policy planning.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Nayagam S, Chan P, Zhao K, et al. Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning. Clin Infect Dis. 2021. PMID: 32255486. doi:10.1093/cid/ciaa134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。